Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed…
TRUEiGTECH Launches TruePredict to Power FIFA World Cup Sports Prediction Platforms for iGaming Operators
Sentire(R) Surgical System Receives EU CE Mark (MDR) and Singapore HSA Approval, Cornerstone Robotics Accelerates Global Strategic Expansion
Unitree Robotics IPO Review Approaches, Shoucheng Holdings Robot Assets Poised for Valuation Re-rating